Xiaobao Xie

4.2k citations
99 papers · 3.3k indexed · 1 hit paper · h-index 23

Xiaobao Xie

92 papers receiving 3.2k citations

Hit Papers

Antibacterial activity and mechanism of silver nanopartic...1.4k20092026201420204008001.2k

Peers

Xiaobao Xie
Comparison fields: 5 of 144
  • Drug Discovery 7
  • Molecular Medicine 186
  • Materials Chemistry 1.6k
  • Biomaterials 355
  • Biomedical Engineering 925
Replace Wenru Li with:
Wenru Li China
Qingshan Shi China
Sekar Vijayakumar India
Ahmad Reza Shahverdi Iran
Sureshbabu Ram Kumar Pandian India
Amit Kumar Mandal India
Venkataraman Deepak India
Young Kyung Park South Korea
Sougata Ghosh India
Fazlurrahman Khan South Korea
Xiaobao Xie relative to Wenru Li China Wenru Li's profile →
Citations per field
00.5×1.5×1.9×
Wenru Li · 1×
Citations per year

Countries citing papers authored by Xiaobao Xie

Since Specialization
Citations

This map shows the geographic impact of Xiaobao Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobao Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobao Xie more than expected).

Fields of papers citing papers by Xiaobao Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobao Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobao Xie. The network helps show where Xiaobao Xie may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xiaobao Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaobao Xie Line = papers co-authored together Xiaobao Xie links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20255
2 20250
3 20251
4 20251
5 20250
6 20250
7 20242
8 202418
9 20237
10 20234
11 20233
12 20225
13 202213
14 202210
15 202023
16 2016115
17 20167
18 201510
19 201471
20
Antibacterial activity and mechanism of silver nanoparticles on Escherichia colibreakdown →
20091366

About Xiaobao Xie

Xiaobao Xie is a scholar working on Molecular Medicine, Microbiology and Organic Chemistry, having authored 99 papers that have together received 3.3k indexed citations. Recurring topics across this work include Bacterial biofilms and quorum sensing (22 papers), Antibiotic Resistance in Bacteria (16 papers), Antimicrobial agents and applications (11 papers), Biopolymer Synthesis and Applications (8 papers), Lignin and Wood Chemistry (8 papers), Carbon and Quantum Dots Applications (8 papers), Bacterial Genetics and Biotechnology (8 papers) and Advanced Nanomaterials in Catalysis (7 papers). The work is most often cited by research in Drug Discovery (7 citations), Molecular Medicine (186 citations) and Materials Chemistry (1.6k citations). Xiaobao Xie has collaborated with scholars based in China, United States and Fiji. Frequent co-authors include Qingshan Shi, Wenru Li, Yiben Chen, Yousheng Ouyang, Haiyan Zeng, Xiao-Mo Huang, Shunshan Duan, Gang Zhou, Tingli Sun and Hong Peng. Their work appears in journals such as PLoS ONE, The Science of The Total Environment and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026